Article de Périodique
"Spice" girls: synthetic cannabinoid intoxication (2011)
Auteur(s) :
SCHNEIR, A. B. ;
CULLEN, J. ;
LY, B. T.
Année
2011
Page(s) :
296-299
Langue(s) :
Anglais
Refs biblio. :
15
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
CANNABINOIDES
;
DROGUES DE SYNTHESE
;
ETUDE DE CAS
;
USAGE RECREATIF
;
ANXIETE
;
INTOXICATION
;
TOXICOLOGIE
Thésaurus géographique
ETATS-UNIS
Résumé :
BACKGROUND: "Spice" refers to various synthetic cannabinoid-containing products that seem to have rapidly become popular recreational drugs of abuse. Very little medical literature currently exists detailing the adverse effects and emergency department (ED) presentations associated with "spice" use.
OBJECTIVES: To describe the presentation of 2 patients who recreationally used a "spice" product and to briefly summarize what is known about "spice" and synthetic cannabinoids.
CASE REPORT: Two patients presented to the ED with, predominantly, anxiety after recreationally using a "spice" product that we subsequently confirmed to contain the synthetic cannabinoids, JWH-018 and JWH-073.
CONCLUSION: We suspect that use of "spice" products may increase. Although anxiety was a prominent presentation in both of the patients described here, undoubtedly, future studies will describe the manifestations of intoxication and toxicity with the various synthetic cannabinoids.
OBJECTIVES: To describe the presentation of 2 patients who recreationally used a "spice" product and to briefly summarize what is known about "spice" and synthetic cannabinoids.
CASE REPORT: Two patients presented to the ED with, predominantly, anxiety after recreationally using a "spice" product that we subsequently confirmed to contain the synthetic cannabinoids, JWH-018 and JWH-073.
CONCLUSION: We suspect that use of "spice" products may increase. Although anxiety was a prominent presentation in both of the patients described here, undoubtedly, future studies will describe the manifestations of intoxication and toxicity with the various synthetic cannabinoids.
Affiliation :
Division of Medical Toxicology, University of California, San Diego Medical Center, San Diego, California 92103-8925, USA
Historique